MicroRNA expression in maturing murine megakaryocytes

por Opalinska, Joanna B., Bersenev, Alexey, Zhang, Zhe, Schmaier, Alec A., Choi, John, Yao, Yu, D'Souza, Janine, Tong, Wei, Weiss, Mitchell J.
Publicado em 2010

The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma

por Spencer, Andrew, Yoon, Sung-Soo, Harrison, Simon J., Morris, Shannon R., Smith, Deborah A., Brigandi, Richard A., Gauvin, Jennifer, Kumar, Rakesh, Opalinska, Joanna B., Chen, Christine
Publicado no Blood (2014)

Identification of antisense nucleic acid hybridization sites in mRNA molecules with self-quenching fluorescent reporter molecules

por Gifford, Lida K., Opalinska, Joanna B., Jordan, David, Pattanayak, Vikram, Greenham, Paul, Kalota, Anna, Robbins, Michelle, Vernovsky, Kathy, Rodriguez, Lesbeth C., Do, Bao T., Lu, Ponzy, Gewirtz, Alan M.
Publicado em 2005

Trisomy 21 enhances human fetal erythro-megakaryocytic development

por Chou, Stella T., Opalinska, Joanna B., Yao, Yu, Fernandes, Myriam A., Kalota, Anna, Brooks, John S. J., Choi, John K., Gewirtz, Alan M., Danet-Desnoyers, Gwenn-ael, Nemiroff, Richard L., Weiss, Mitchell J.
Publicado em 2008

Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study

por Trudel, Suzanne, Lendvai, Nikoletta, Popat, Rakesh, Voorhees, Peter M., Reeves, Brandi, Libby, Edward N., Richardson, Paul G., Hoos, Axel, Gupta, Ira, Bragulat, Veronique, He, Zangdong, Opalinska, Joanna B., Cohen, Adam D.
Publicado no Blood Cancer J (2019)

MM-250: Impact of Prolonged Dose Delays on Response with Belantamab Mafodotin (Belamaf; GSK2857916) Treatment in the DREAMM-2 Study: 13-Month Follow-Up

por Cohen, Adam D, Lee, Hans C, Trudel, Suzanne, Abdallah, Al-Ola, Callander, Natalie, Libby, Edward, Karlin, Lionel, Lonial, Sagar, Womersley, Lynsey, Baron, January, Lewis, Eric, Nungesser, Katlyn, Gupta, Ira, Opalinska, Joanna
Publicado no Clin Lymphoma Myeloma Leuk (2020)

Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study

por Richardson, Paul G., Lee, Hans C., Abdallah, Al-Ola, Cohen, Adam D., Kapoor, Prashant, Voorhees, Peter M., Hoos, Axel, Wang, Karrie, Baron, January, Piontek, Trisha, Byrne, Julie, Richmond, Scott, Jewell, Roxanne C., Opalinska, Joanna, Gupta, Ira, Lonial, Sagar
Publicado no Blood Cancer J (2020)

Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells

por Chou, Stella T., Byrska-Bishop, Marta, Tober, Joanna M., Yao, Yu, VanDorn, Daniel, Opalinska, Joanna B., Mills, Jason A., Choi, John Kim, Speck, Nancy A., Gadue, Paul, Hardison, Ross C., Nemiroff, Richard L., French, Deborah L., Weiss, Mitchell J.
Publicado em 2012

A Phase I, Open-Label, Two-Stage Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral AKT Inhibitor GSK2141795 in Patients with Solid T...

por Aghajanian, Carol, Bell-McGuinn, Katherine M., Burris, Howard A., Siu, Lillian L., Stayner, Lee-Ann, Wheler, Jennifer J., Hong, David S., Kurkjian, Carla, Pant, Shubham, Santiago-Walker, Ademi, Gauvin, Jennifer L., Antal, Joyce M., Opalinska, Joanna B., Morris, Shannon R., Infante, Jeffrey R.
Publicado no Invest New Drugs (2018)

Targeting B-Cell Maturation Antigen with GSK2857916 Antibody-Drug Conjugate in Relapsed or Refractory Multiple Myeloma: A Dose-Escalation and Expansion Phase 1 Trial (BMA117159)

por Trudel, Suzanne, Lendvai, Nikoletta, Popat, Rakesh, Voorhees, Peter M., Reeves, Brandi, Libby, Edward N., Richardson, Paul G., Anderson, Larry D., Sutherland, Heather J., Yong, Kwee, Hoos, Axel, Gorczyca, Michele M., Lahiri, Soumi, He, Zangdong, Austin, Daren J., Opalinska, Joanna B., Cohen, Adam D.
Publicado no Lancet Oncol (2018)

Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study

por Farooq, Asim V., Degli Esposti, Simona, Popat, Rakesh, Thulasi, Praneetha, Lonial, Sagar, Nooka, Ajay K., Jakubowiak, Andrzej, Sborov, Douglas, Zaugg, Brian E., Badros, Ashraf Z., Jeng, Bennie H., Callander, Natalie S., Opalinska, Joanna, Baron, January, Piontek, Trisha, Byrne, Julie, Gupta, Ira, Colby, Kathryn
Publicado no Ophthalmol Ther (2020)

Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study

por Farooq, Asim V., Degli Esposti, Simona, Popat, Rakesh, Thulasi, Praneetha, Lonial, Sagar, Nooka, Ajay K., Jakubowiak, Andrzej, Sborov, Douglas, Zaugg, Brian E., Badros, Ashraf Z., Jeng, Bennie H., Callander, Natalie S., Opalinska, Joanna, Baron, January, Piontek, Trisha, Byrne, Julie, Gupta, Ira, Colby, Kathryn
Publicado no Ophthalmol Ther (2020)

Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM)

por Lonial, Sagar, Nooka, Ajay K., Thulasi, Praneetha, Badros, Ashraf Z., Jeng, Bennie H., Callander, Natalie S., Potter, Heather A., Sborov, Douglas, Zaugg, Brian E., Popat, Rakesh, Degli Esposti, Simona, Byrne, Julie, Opalinska, Joanna, Baron, January, Piontek, Trisha, Gupta, Ira, Dana, Reza, Farooq, Asim V., Colby, Kathryn, Jakubowiak, Andrzej
Publicado no Blood Cancer J (2021)

Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis

por Alvarez, Hector, Opalinska, Joanna, Zhou, Li, Sohal, Davendra, Fazzari, Melissa J., Yu, Yiting, Montagna, Christina, Montgomery, Elizabeth A., Canto, Marcia, Dunbar, Kerry B., Wang, Jean, Roa, Juan Carlos, Mo, Yongkai, Bhagat, Tushar, Ramesh, K. H., Cannizzaro, Linda, Mollenhauer, J., Thompson, Reid F., Suzuki, Masako, Meltzer, Stephen, Melnick, Ari, Greally, John M., Maitra, Anirban, Verma, Amit
Publicado em 2011

Correction: Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis

por Alvarez, Hector, Opalinska, Joanna, Zhou, Li, Sohal, Davendra, Fazzari, Melissa J., Yu, Yiting, Montagna, Christina, Montgomery, Elizabeth A., Canto, Marcia, Dunbar, Kerry B., Wang, Jean, Roa, Juan Carlos, Mo, Yongkai, Bhagat, Tushar, Ramesh, K. H., Cannizzaro, Linda, Mollenhauer, J., Thompson, Reid F., Suzuki, Masako, Meltzer, Stephen, Melnick, Ari, Greally, John M., Maitra, Anirban, Verma, Amit
Publicado em 2011

Aberrant Epigenetic and Genetic Marks Are Seen in Myelodysplastic Leukocytes and Reveal Dock4 as a Candidate Pathogenic Gene on Chromosome 7q

por Zhou, Li, Opalinska, Joanna, Sohal, Davendra, Yu, Yiting, Mo, Yongkai, Bhagat, Tushar, Abdel-Wahab, Omar, Fazzari, Melissa, Figueroa, Maria, Alencar, Cristina, Zhang, Jinghang, Kambhampati, Suman, Parmar, Simrit, Nischal, Sangeeta, Hueck, Christoph, Suzuki, Masako, Freidman, Ellen, Pellagatti, Andrea, Boultwood, Jacqueline, Steidl, Ulrich, Sauthararajah, Yogen, Yajnik, Vijay, Mcmahon, Christine, Gore, Steven D., Platanias, Leonidas C., Levine, Ross, Melnick, Ari, Wickrema, Amittha, Greally, John M., Verma, Amit
Publicado em 2011